13 completed, 3 withdrawn, 2 active not recruiting, 2 recruiting. 12 Phase 2, 4 Phase 1, 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 8, Terminated 2, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 4 | Active not recruiting 2, Terminated 1, Unknown 1 |
| Not applicable | 3 | Withdrawn 2, Recruiting 1 |
Follow Lymphoma, AIDS-Related: new trials by email Literature Review of Lymphoma, AIDS-Related trials Research Report on Lymphoma, AIDS-Related
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma Oral Antiretroviral Therapy, albuvirtide, Cabotegravir/Rilpivirine - AIDS-related Lymphoma, HIV Infection | Not applicable | Recruiting | Shanghai Public Health Clinical Center | 60 | 2026-05-26 | 2026-07-27 |
| Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC Non-Interventional, Non-Interventional Follow-up - HIV-Associated Malignant Neoplasm, HIV Infections | Completed | AIDS Malignancy Consortium | 460 | 2023-07-25 | 2026-08-14 | |
| Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia ThisCART19A - AIDS Related Lymphoma and Lympholeukemia | Phase 1 | Unknown | He Huang | 18 | 2022-03-18 | 2022-04-22 |
| A Registry Study on HIV-related Lymphoma AIDS Related Lymphoma, HIV Related Lymphoma | Recruiting | Rotkreuzklinikum München gGmbH | 300 | 2021-08-25 | 2023-04-06 | |
| Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - AIDS-Related Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 46 | 2018-03-16 | 2026-08-11 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Lenalidomide, Rituximab, Prednisone - Primary Effusion Lymphoma, B-Cell Neoplasm | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 17 | 2017-07-03 | 2026-10-20 |
| Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma | Phase 2 | Completed | AIDS Malignancy Consortium | 7 | 2016-09-15 | 2022-10-10 |
| Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy Retrospective survival analysis - Central Nervous System Lymphoma, AIDS Related Lymphoma | Completed | Fondation Ophtalmologique Adolphe de Rothschild | 51 | 2015-03-15 | 2018-10-01 | |
| Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma carmustine, cytarabine, melphalan - Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma | Not applicable | Withdrawn | Fred Hutchinson Cancer Center | 2015-02-01 | 2015-05-07 | |
| High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC) - AIDS-related Lymphoma, HIV Infections | Phase 1 / Phase 2 | Terminated | Universitätsklinikum Hamburg-Eppendorf | 5 | 2008-11-28 | 2022-09-08 |
| A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL R-EPOCH and cART - Lymphoma, AIDS Related, HIV Infections | Phase 2 | Completed | Ontario Clinical Oncology Group (OCOG) | 6 | 2008-02-01 | 2013-09-12 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom DNA analysis, polymorphism analysis, laboratory biomarker analysis - Bladder Cancer, Brain and Central Nervous System Tumors | Unknown | Cancer Research UK | 14000 | 2008-02-01 | 2013-08-26 | |
| Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer aprepitant, ondansetron hydrochloride - Myeloproliferative Disorders, Leukemia | Not applicable | Withdrawn | Vanderbilt-Ingram Cancer Center | 2007-08-01 | 2013-04-02 | |
| High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk Rituximab and CHOP regimen + PBSCT - HIV-related Lymphoma, HIV Infections | Phase 2 | Completed | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 27 | 2007-01-01 | 2016-08-19 |
| Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma cisplatin, cytarabine, etoposide - AIDS-related Lymphoma, Adult Non-Hodgkin's Lymphoma | Phase 2 | Withdrawn | AIDS Malignancy Consortium | 2006-02-01 | 2016-02-03 | |
| Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma HIV Infections, Lymphoma, AIDS-Related | Completed | National Institutes of Health Clinical Center (CC) | 120 | 2005-09-20 | 2017-07-02 | |
| EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection Rituximab, Filgrastim, EPOCH - Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse | Phase 2 | Completed | National Cancer Institute (NCI) | 68 | 2001-01-29 | 2026-08-03 |
| Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma rituximab, CHOP - AIDS Related Lymphoma | Phase 2 | Terminated | French National Agency for Research on AIDS and Viral Hepatitis | 60 | 1999-01-01 | 2005-08-17 |
| Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease filgrastim, cyclophosphamide, etoposide - Lymphoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 5 | 1997-07-01 | 2010-06-11 |
| A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines HIV Infections, Lymphoma, AIDS-Related | Completed | National Cancer Institute (NCI) | 20 | 1997-02-01 | 2008-03-04 |
Showing 20 of 25. Sign in to see all of them.
HIV Infections (10) · Lymphoma, Non-Hodgkin (10) · Lymphoma (8) · Acquired Immunodeficiency Syndrome (6) · Lymphoma, Large B-Cell, Diffuse (4) · Burkitt Lymphoma (3) · Hodgkin Disease (3) · Intraocular Lymphoma (3) · Lymphoma, Follicular (3) · Lymphoma, Large-Cell, Anaplastic (3) · Lymphoma, Large-Cell, Immunoblastic (3) · Lymphoma, T-Cell, Cutaneous (3) · Lymphoproliferative Disorders (3) · Neoplasms (3)
Hemic and Lymphatic Diseases (25) · Immune System Diseases (25) · Immunoproliferative Disorders (25) · Lymphatic Diseases (25) · Neoplasms by Histologic Type (25) · Lymphoma, B-Cell (24) · Lymphoproliferative Disorders (22) · Neoplasms (22) · Lymphoma (17) · Lymphoma, Non-Hodgkin (15) · Virus Diseases (15) · Infections (14) · Immunologic Deficiency Syndromes (12) · Urogenital Diseases (12) · Blood-Borne Infections (11)
Etoposide (9) · Rituximab (8) · Cyclophosphamide (7) · Prednisone (6) · Vincristine (6) · Doxorubicin (5) · Filgrastim (4) · Cytarabine (3) · Carmustine (2) · Lomustine (2) · Melphalan (2) · Peripheral Blood Stem Cell Transplantation (2) · Procarbazine (2) · Radiotherapy (2) · Amplified Fragment Length Polymorphism Analysis (1)
National Cancer Institute (NCI) (5) · AIDS Malignancy Consortium (3) · Atara Biotherapeutics (1) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · Cancer Research UK (1) · Case Comprehensive Cancer Center (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Fred Hutchinson Cancer Center (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Genzyme, a Sanofi Company (1) · He Huang (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institutes of Health Clinical Center (CC) (1) · Ontario Clinical Oncology Group (OCOG) (1) · Ribozyome (1)
United States (12) · China (2) · France (2) · Germany (2) · United Kingdom (2) · Canada (1) · Italy (1) · Kenya (1) · Netherlands (1) · Puerto Rico (1) · Spain (1) · Zimbabwe (1)
Aditi Mehta, DO (1) · Alexandra M. Levine, MD (1) · Anil Tulpule, MD (1) · Ann C. Collier (1) · Ann Woolfrey (1) · Anna E Coghill, PhD, MPH (1) · Barbara A. Murphy, MD (1) · Charles S. Rabkin (1) · Christopher Melani, M.D. (1) · David A. Wohl (1) · Dominique Costagliola (1) · Francois Boue, MD (1) · Giuseppe Rossi, MD (1) · He Huang, Doctor (1) · Ida C Wong-Sefidan (1)
PMID 30125215, PMID 20130244, PMID 21289631, PMID 24224624, PMID 38427337, PMID 38625984, PMID 41429707
UM1CA121947 (2), P30CA015704 (1), P30CA043703 (1), U01CA121947 (1)